How Should We Define Major Bleeding Events in Thromboprophylaxis?
- Prophylaxis for Thromboembolism in Hospitalized Medical Patients. Famularo, Giuseppe; Minisola, Giovanni; De Simone, Claudio // New England Journal of Medicine;7/19/2007, Vol. 357 Issue 3, p304
A letter to the editor is presented in response to the article "Prophylaxis for thromboembolism in hospitalized medical patients," by C. W. Francis in the April 5, 2007 issue.
- Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin. Danguy, Christine; Biston, Patrick; Carlier, Eric; Defrance, Pierre; Piagnerelli, Michael // Intensive Care Medicine;Nov2012, Vol. 38 Issue 11, p1904
A letter to the editor is presented which discusses the use of low-molecular-weight heparin (LMWH) in intensive care unit (ICU) patients for thrombosis prevention and three case studies of severe hyperkalemia induced by enoxaparin doses.
- Detecting the effects of thromboprophylaxis: The case of the rogue reviews. Petticrew, Mark; Kennedy, Susan C. // BMJ: British Medical Journal (International Edition);09/13/97, Vol. 315 Issue 7109, p665
Relates an incident showing the importance of mechanical methods in preventing deep vein thrombosis in patients at moderate and high risk. Mechanical methods as alternative to systemic reviews and meta-analyses; Health benefits of the mechanical method; Elements of a good review; Aid of a...
- Catching blood clots before they do damage. Bradley, David // New Scientist;5/04/96, Vol. 150 Issue 2028, p18
Reports on the development of a molecular claw for marking a potentially fatal thrombosis. Statistics; Use of technetium-99; Success of tests on dogs; Plans and expectations.
- The Assessment of Deep Vein Thromboses for Therapeutic Trials. Leizorovicz, Alain; Kassai, Behrouz; Becker, François; Cucherat, Michel // Angiology;Jan2003, Vol. 54 Issue 1, p19
In the current paper, we provide recommendations for the assessment of deep vein thromboses for the purpose of therapeutic trials evaluating antithrombotic drugs in the prevention of deep venous thrombosis. We have reviewed recently published articles on diagnostic and therapeutic studies, and...
- Lovenox cleared for at-home use. // Drug Topics;2/16/98, Vol. 124 Issue 4, p7
Reports that the Lovenox injection marketed by Rhone-Poulenc Rorer, which may help prevent deep-vein thrombosis after hip-replacement surgery, can be administered at home. Description of the drug.
- Combat clogs. Munson, Marty; Yeykal, Teresa // Prevention;Sep95, Vol. 47 Issue 9, p50
Recommends eating folate-rich foods to lower homocysteine levels. Link between homocysteine and deep vein thrombosis.
- CORRESPONDENCE. Freeling, Paul; Barry, S.M.K.; Byrne, P.S.; Leonard, Colin J.; Varnam, M.A.; Murley, Reginald; Cooper, Christine; Cotton, L.T.; Doran, F.S.A.; Rooke, G.B.; Dempsey, A.N.; Ward, F.G.; Paterson, A. Spencer; Panton, Neil; Harrison, Elizabeth A.; Morgan, D.H.; Ghodse, A. Hamid; Leeming, J.J. // British Medical Journal;11/13/1976, Vol. 2 Issue 6045, p1191
Presents letters related to medicine to the editors of the 'British Medical Journal' in Great Britain. Prevention of postoperative deep venous thrombosis; Abuse of herbal cigarettes containing stramonium; Diet for diabetics.
- Prevention of postoperative deep vein thrombosis by leg bandaging and oxyphenbutazone. Fillberg, Rengy // British Medical Journal;5/22/1976, Vol. 1 Issue 6020, p1256
Investigates the prevention of postoperative deep vein thrombosis by leg bandaging and oxyphenbutazone. Effects of bleeding as a result of an orthopaedic operation; Increase in the venous blood velocity through bandaging; Risks of substance overdose.